Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Biallelic Ndufa13 Variants Lead to a Neurodevelopmental Phenotype With Gradual Neurological Impairment Publisher



Kaiyrzhanov R1, 2 ; Thompson K3 ; Efthymiou S1 ; Mukushev A4 ; Zharylkassyn A5 ; Prasad C6 ; Karimiani EG1, 7 ; Alvi JR8 ; Niyazov D9 ; Alahmad A10 ; Babaei M11 ; Tajsharghi H12 ; Albash B13 ; Alaqeel A13 Show All Authors
Authors
  1. Kaiyrzhanov R1, 2
  2. Thompson K3
  3. Efthymiou S1
  4. Mukushev A4
  5. Zharylkassyn A5
  6. Prasad C6
  7. Karimiani EG1, 7
  8. Alvi JR8
  9. Niyazov D9
  10. Alahmad A10
  11. Babaei M11
  12. Tajsharghi H12
  13. Albash B13
  14. Alaqeel A13
  15. Charif M14, 15, 16
  16. Hashemi N17
  17. Heidari M18
  18. Kalantar SM19
  19. Lenaers G20, 21
  20. Mehrjardi MYV22
  21. Srinivasan VM23
  22. Gowda VK23
  23. Mirabutalebi SH19
  24. Carere DA24
  25. Movahedinia M25
  26. Murphy D26
  27. Mcfarland R3, 27
  28. Abdelhamid MS28
  29. Elhossini RM29
  30. Alavi S1
  31. Napier M24
  32. Belangerquintana A30
  33. Prasad AN31
  34. Jakobczyk J6
  35. Roubertie A32
  36. Rupar T33, 34
  37. Sultan T8
  38. Toosi MB17, 35
  39. Sazanov L36
  40. Severino M37
  41. Houlden H1
  42. Taylor RW3, 27
  43. Maroofian R1

Source: Brain Communications Published:2025


Abstract

Biallelic variants in NADH (nicotinamide adenine dinucleotide (NAD) + hydrogen (H))-ubiquinone oxidoreductase 1 alpha subcomplex 13 have been linked to mitochondrial complex I deficiency, nuclear type 28, based on three affected individuals from two families. With only two families reported, the clinical and molecular spectrum of NADH-ubiquinone oxidoreductase 1 alpha subcomplex 13–related diseases remains unclear. We report 10 additional affected individuals from nine independent families, identifying four missense variants (including recurrent c.170G > A) and three ultra-rare or novel predicted loss-of-function biallelic variants. Updated clinical–radiological data from previously reported families and a literature review compiling clinical features of all reported patients with isolated complex I deficiency caused by 43 genes encoding complex I subunits and assembly factors are also provided. Our cohort (mean age 7.8 ± 5.4 years; range 2.5–18) predominantly presented a moderate-to-severe neurodevelopmental syndrome with oculomotor abnormalities (84%), spasticity/hypertonia (83%), hypotonia (69%), cerebellar ataxia (66%), movement disorders (58%) and epilepsy (46%). Neuroimaging revealed bilateral symmetric T2 hyperintense substantia nigra lesions (91.6%) and optic nerve atrophy (66.6%). Protein modeling suggests missense variants destabilize a critical junction between the hydrophilic and membrane arms of complex I. Fibroblasts from two patients showed reduced complex I activity and compensatory complex IV activity increase. This study characterizes NADH-ubiquinone oxidoreductase 1 alpha subcomplex 13–related disease in 13 individuals, highlighting genotype–phenotype correlations. © The Author(s) 2024.
Other Related Docs
7. Clinical Spectrum in Multiple Families With Primary Coq10 Deficiency, American Journal of Medical Genetics# Part A (2021)
11. Phenotypic Continuum of Nfu1-Related Disorders, Annals of Clinical and Translational Neurology (2022)
19. Genetic Analysis of Mecp2 Gene in Iranian Patients With Rett Syndrome, Iranian Journal of Child Neurology (2019)